Impact BioMedical Inc.
IBO
$0.4324
$0.00741.74%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -27.11M | 4.25M | -887.00K | -962.00K | -1.24M |
| Total Depreciation and Amortization | 2.00K | 2.00K | 1.00K | 2.00K | 1.00K |
| Total Amortization of Deferred Charges | 277.00K | 279.00K | 278.00K | 278.00K | 279.00K |
| Total Other Non-Cash Items | 25.99M | -5.68M | 5.00K | -36.00K | -26.00K |
| Change in Net Operating Assets | -412.00K | -139.00K | -63.00K | 6.00K | 548.00K |
| Cash from Operations | -1.26M | -1.29M | -666.00K | -712.00K | -433.00K |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 1.00K | 1.00K | -- | 1.00K |
| Cash from Investing | 0.00 | 1.00K | 1.00K | -- | 1.00K |
| Total Debt Issued | 587.00K | 224.00K | 665.00K | 713.00K | 232.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 3.73M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 587.00K | 3.95M | 665.00K | 713.00K | 232.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -669.00K | 2.67M | 0.00 | 1.00K | -200.00K |